Comments
Loading...

Pyxis Oncology

PYXSNASDAQ
Logo brought to you by Benzinga Data
$1.57
-0.05-3.09%
Pre-Market: 7:20 AM EDT

Pyxis Oncology (NASDAQ:PYXS) Stock Quotes, Forecast and News Summary

Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Aug 24
1
Sep 24
3
1
Nov 24
2
Dec 24
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open-
Close-
Volume / Avg.231.00 / 1.29M
Day Range- - -
52 Wk Range1.39 - 6.85
Market Cap$93.36M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
44
Short Interest-
Days to Cover10.41

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PYXS

FAQ

Q

How do I buy Pyxis Oncology (PYXS) stock?

A

You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Pyxis Oncology (PYXS) competitors?

A

There are no as such competitors for Pyxis Oncology.

Q

What is the forecast, or price target, for Pyxis Oncology (PYXS) stock?

A

Pyxis Oncology has a consensus price target of $10.56.

Q

What is the current price for Pyxis Oncology (PYXS)?

A

The stock price for Pyxis Oncology (NASDAQ: PYXS) is $1.57 last updated January 31, 2025 at 7:20 AM EST.

Q

Does Pyxis Oncology (PYXS) pay a dividend?

A

There are no upcoming dividends for Pyxis Oncology.

Q

When is Pyxis Oncology (NASDAQ:PYXS) reporting earnings?

A

Pyxis Oncology’s Q4 earnings are confirmed for Thursday, March 20, 2025.

Q

Is Pyxis Oncology (PYXS) going to split?

A

There is no upcoming split for Pyxis Oncology.

Q

What sector and industry does Pyxis Oncology (PYXS) operate in?

A

Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.